Patent ID: 6617342
Filing Date: 2003-09-09
Classification: A61P,C07D

Abstract:
A compound selected from the group consisting of:4-(4-[2-(2-Phenyl-4-oxazolyl)ethoxy]phenylsulfonyl)-1H,2H-pyrazolin-3-one; 4-(4-[2-(2-Phenyl-4-oxazolyl)ethoxy]phenylmethylsulfonyl)-1H,2H-pyrazolin-3-one; 3-(4-(2-Phenyl-4-oxazolyl)ethoxy)phenyl-4-methylsulfonyl-1H-1,2-pyrazoline; 2-Naphthylsulfonyl-pyrazolin-3-one; and 6-(2-Fluorobenzyloxy)-2-naphthylsulfonyl-pyrazolin-3-one; or a pharmaceutically acceptable salt or prodrug thereof.